ResMed Named Top Corporate Citizen by Forbes, JUST for Second Straight Year

SAN DIEGO – December 12, 2017 – ResMed today was named one of America’s top 100 corporate citizens for the second straight year by Forbes and JUST Capital, a nonprofit that analyzes and ranks companies based on how they serve the priorities of the American people.

ResMed ranked #76 among other large publicly traded U.S. companies – #2 in “Health Care Equipment & Services” – when compared on issues including:

  • Worker compensation and wellbeing
  • Customer treatment
  • Product impact
  • Environmental impact
  • Community support
  • Job creation

“This honor acknowledges that here at ResMed, we are fulfilling our commitment to best serve our patients, physicians, providers, communities, and our 6,000 ResMedians serving people in 120 countries worldwide,” said ResMed CEO Mick Farrell. “Congratulations to every member of our ResMed family for helping raise the bar in product and service excellence as well as in social responsibility and caring deeply for the people in the communities we serve. I look forward to us raising it even higher in 2018.”

See every 2017 JUST 100 company here, or in the December 26 printed issue of Forbes.

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com | Facebook | Twitter | LinkedIn

# # #

Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

[email protected]

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages